Lazard Asset Management’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
+173,902
New +$1.92M ﹤0.01% 1078
2025
Q3
Sell
-84,155
Closed -$938K 2173
2025
Q2
$938K Buy
84,155
+80,007
+1,929% +$991K ﹤0.01% 1319
2025
Q1
$67K Buy
4,148
+1,552
+60% +$27.2K ﹤0.01% 1927
2024
Q4
$45K Buy
+2,596
New +$45.1K ﹤0.01% 1991
2022
Q2
Sell
-3,778
Closed -$123K 2511
2022
Q1
$123K Sell
3,778
-42
-1% -$1.35K ﹤0.01% 1345
2021
Q4
$118K Buy
3,820
+339
+10% +$11.3K ﹤0.01% 1397
2021
Q3
$132K Buy
+3,481
New +$139K ﹤0.01% 1359
2021
Q1
Sell
-777
Closed -$33K 1964
2020
Q4
$33K Sell
777
-716
-48% -$26.2K ﹤0.01% 1533
2020
Q3
$46K Sell
1,493
-142
-9% -$4.4K ﹤0.01% 1211
2020
Q2
$52K Buy
1,635
+76
+5% +$2.52K ﹤0.01% 1219
2020
Q1
$43K Buy
+1,559
New +$60.3K ﹤0.01% 1235
2019
Q4
Sell
-53
Closed -$2K 1625
2019
Q3
$2K Buy
+53
New +$2.73K ﹤0.01% 1405

Other funds holding OFIX

Lazard Asset Management's OFIX Position: Q2 2026 in Review

Lazard Asset Management opened a new position in Orthofix Medical (OFIX) in Q2 2026: 173,902 shares worth $1.59M. The stake represents ﹤0.01% of the portfolio and ranks #1078 among its holdings. This is a return to the name: Lazard Asset Management previously reported a position in OFIX as recently as Q2 2025.

Lazard Asset Management first reported a position in OFIX in Q3 2019 and has held it in 12 quarters since. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Lazard Asset Management held 173,902 shares of Orthofix Medical worth $1.59M as of Q2 2026.
  • Orthofix Medical was a new Lazard Asset Management position in Q2 2026.
  • Orthofix Medical made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1078 holding.
  • Lazard Asset Management first reported a position in Orthofix Medical in Q3 2019 and has held it in 12 quarters since.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.